Exogenous Insulin Antibody Syndrome and Subsequent Severe Subcutaneous Insulin Resistance Complicating Type 1 Diabetes
JCEM Case Reports · 03.12.2025 · 4 (1)
DOI: 10.1210/jcemcr/luaf300 ↗Kurz gefasst
Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 30.12.2025. Verfasst von Vicki Cunningham und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Te Whatu Ora-Health New Zealand, Whangarei 0148, New Zealand. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
A young girl with type 1 diabetes mellitus (T1D) developed exogenous insulin antibody syndrome (EIAS) characterized by daytime hyperglycemia and ketosis alternating with prolonged severe nocturnal hypoglycemia. EIAS was diagnosed after the exclusion of other causes of hypoglycemia and with confirmation of very high insulin autoantibody levels, high plasma levels of bound insulin, and abnormal insulin clearance. Treatment with different insulin analogues, subcutaneous (SC) insulin pump, immunomodulation using corticosteroids, and intravenous (IV) immunoglobulin were not effective. She responded well to B-lymphocyte depletive therapy (rituximab) with a fall in insulin antibody levels and returned to usual T1D management with a marked improvement in severity of hypoglycemia. One year later she developed hyperglycemia and ketosis and showed no glycemic effect from SC insulin. She became dependent on IV insulin and was diagnosed with severe subcutaneous insulin resistance (SIR). She managed IV insulin at home but developed episodes of sepsis and central line blockage. Many treatment strategies failed, but successful management was finally achieved with the addition of heparin to insulin lispro via SC pump. EIAS and SIR are both extremely rare and, in this case, responded to very different treatment approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, Te Whatu Ora-Health New Zealand, Whangarei 0148, New Zealand.
- Department of Pathology and Laboratory Medicine, Te Whatu Ora-Health New Zealand, Auckland 1010, New Zealand.
- Pathology, Surgical and Support Services, Te Whatu Ora-Health New Zealand, Whangarei 0148, New Zealand.
- Department of Paediatric Immunology, Starship Child Health, Te Whatu Ora-Health New Zealand, Auckland 1050, New Zealand.
- Department of Paediatrics, The University of Auckland, Auckland 1050, New Zealand.
- Liggins Institute, The University of Auckland, Auckland 1050, New Zealand.
ORCID-Profile: Vicki Cunningham, Leo Lam, Benjamin Albert
Zitieren
APA
Cunningham, V., Lam, L., Hsiao, K. C., Ayers, R., Albert, B., & Jefferies, C. (2025). Exogenous Insulin Antibody Syndrome and Subsequent Severe Subcutaneous Insulin Resistance Complicating Type 1 Diabetes. JCEM Case Reports, 4(1). https://doi.org/10.1210/jcemcr/luaf300
Vancouver
Cunningham V, Lam L, Hsiao KC, Ayers R, Albert B, Jefferies C. Exogenous Insulin Antibody Syndrome and Subsequent Severe Subcutaneous Insulin Resistance Complicating Type 1 Diabetes. JCEM Case Reports. 2025;4(1). doi:10.1210/jcemcr/luaf300
BibTeX
@article{Cunningham2025,
author = {Cunningham, Vicki and Lam, Leo and Hsiao, Kuang-Chih and Ayers, Rosemary and Albert, Benjamin and Jefferies, Craig},
title = {Exogenous Insulin Antibody Syndrome and Subsequent Severe Subcutaneous Insulin Resistance Complicating Type 1 Diabetes},
journal = {JCEM Case Reports},
year = {2025},
volume = {4},
number = {1},
doi = {10.1210/jcemcr/luaf300}
}
EUVIMED